Man Group’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Sell
290,028
-124,456
-30% -$1.39M ﹤0.01% 1379
2026
Q1
$4.93M Buy
414,484
+325,710
+367% +$3.33M 0.01% 1165
2025
Q4
$884K Buy
88,774
+17,371
+24% +$166K ﹤0.01% 1714
2025
Q3
$639K Buy
+71,403
New +$661K ﹤0.01% 1793
2025
Q2
Sell
-31,646
Closed -$343K 2156
2025
Q1
$343K Buy
+31,646
New +$318K ﹤0.01% 1901
2024
Q4
Sell
-10,137
Closed -$114K 1972
2024
Q3
$114K Buy
+10,137
New +$108K ﹤0.01% 1892
2023
Q3
Hold
0
1843
2023
Q1
Hold
0
1164
2022
Q2
Hold
0
1446
2022
Q1
Sell
-8,211
Closed -$201K 2168
2021
Q4
$201K Sell
8,211
-18,389
-69% -$432K ﹤0.01% 1803
2021
Q3
$620K Buy
26,600
+12,900
+94% +$312K ﹤0.01% 1482
2021
Q2
$376K Sell
13,700
-49,055
-78% -$1.4M ﹤0.01% 1632
2021
Q1
$2.31M Buy
+62,755
New +$2.22M 0.01% 1052

Other funds holding AHCO

Man Group's AHCO Position: Q2 2026 in Review

Man Group reduced its AdaptHealth (AHCO) stake by 30% in Q2 2026, selling an estimated $1.39M and leaving 290,028 shares worth $3.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1379.

Man Group first reported a position in AHCO in Q1 2021 and has held it in 10 quarters since. The position peaked at $4.93M in Q1 2026. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Man Group held 290,028 shares of AdaptHealth worth $3.02M as of Q2 2026.
  • Man Group sold 124,456 AdaptHealth shares in Q2 2026, an estimated $1.39M.
  • AdaptHealth made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1379 holding.
  • Man Group first reported a position in AdaptHealth in Q1 2021 and has held it in 10 quarters since.
  • Man Group's AdaptHealth position peaked at $4.93M in Q1 2026.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.